Glioblasztóma: vizsgálatok itt: Kína
58 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Clinical Trial of P134 Cells in Recurrent Glioblastoma
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 26
- Run by
- Tasly Pharmaceutical Group Co., Ltd
See details and how to joinNCT07318818 - 1/2. fázisTaking peopleBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Beijing
- Életkor
- 8 év to 85 év
- People
- 85
- Run by
- Essen Biotech
See details and how to joinNCT07410494 - 1/2. fázisTaking peopleEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Where
- Beijing
- People
- 83
- Run by
- Essen Biotech
See details and how to joinNCT07410676 - No phaseTaking peopleMRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
- Where
- Shenyang
- Életkor
- 18 év to 80 év
- People
- 20
- Run by
- Shengjing Hospital
See details and how to joinNCT05957679 - 1/2. fázisTaking peopleClinical Study of Oncolytic Virus in Glioblastoma
- Where
- Mianyang
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Mianyang Central Hospital
See details and how to joinNCT07145047 - No phaseTaking peopleMagnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion
- Where
- Shenyang
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Shengjing Hospital
See details and how to joinNCT05990244 - Korai 1. fázisNot yet taking people in KínaSafety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
- Where
- Hangzhou
- Életkor
- 19 év to 70 év
- People
- 36
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07244666 - 1. fázisTaking peopleB7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 14
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07193628 - 2. fázisTaking peopleStupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 38
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07193654 - No phaseTaking peopleAllogeneic γδT Cells in Glioblastoma
- Where
- Beijing, Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- Peking University Third Hospital
See details and how to joinNCT07144735 - 2. fázisCsak meghívásosSonodynamic-Chemoradiotherapy Integration in Glioblastoma
- Where
- Zhengzhou
- Életkor
- Up to 75 év
- People
- 230
- Run by
- Yingjuan Zheng
See details and how to joinNCT07130149 - Korai 1. fázisTaking peopleClinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 15
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07067905 - 1. fázisTaking peopleBC008-1A Injection for Recurrent CNS WHO G4 Glioma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 40
- Run by
- Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
See details and how to joinNCT06773481 - 1. fázisTaking peopleSafety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
- Where
- Beijing, Changchun
- Életkor
- 18 év and over
- People
- 102
- Run by
- Chipscreen Biosciences, Ltd.
See details and how to joinNCT06902350 - 2. fázisTaking peopleA Study of BL-B01D1 in Patients With Recurrent Glioblastoma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 20
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06598787 - No phaseNot yet taking people in KínaPhotodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 100
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06939400 - 2. fázisTaking peopleEnhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 200
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06936046 - 1/2. fázisCsak meghívásosEvaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
- Where
- Jinan
- Életkor
- 18 év and over
- People
- 100
- Run by
- Man Hu
See details and how to joinNCT06690216 - Korai 1. fázisTaking peopleSafety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 15
- Run by
- Zhongnan Hospital
See details and how to joinNCT06757153 - No phaseTaking peopleHypofractionated Radiotherapy
- Where
- Changchun
- Életkor
- 18 év to 70 év
- People
- 420
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT06740955 - 1/2. fázisTaking peopleTIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
- Where
- Beijing
- Életkor
- 16 év to 90 év
- People
- 85
- Run by
- Essen Biotech
See details and how to joinNCT06640582 - 1. fázisCsak meghívásosThe Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 50
- Run by
- Shanghai Simnova Biotechnology Co.,Ltd.
See details and how to joinNCT06616727 - 2. fázisTaking peopleJK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- JenKem Technology Co., Ltd.
See details and how to joinNCT06595186 - No phaseTaking peopleResearch on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- First Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT05990556 - No phaseNot yet taking people in KínaSub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 326
- Run by
- Huashan Hospital
See details and how to joinNCT06368934